Fuji Pharma Co., Ltd. (FRA:FUP)
Germany flag Germany · Delayed Price · Currency is EUR
9.70
+0.05 (0.52%)
At close: Dec 1, 2025

Fuji Pharma Revenue

In the fiscal year ending September 30, 2025, Fuji Pharma had annual revenue of 51.68B JPY with 12.01% growth. Fuji Pharma had revenue of 14.72B in the quarter ending September 30, 2025, with 13.40% growth.

Revenue
51.68B JPY
Revenue Growth
+12.01%
P/S Ratio
0.81
Revenue / Employee
31.17M JPY
Employees
1,658
Market Cap
239.66M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202551.68B5.54B12.01%
Sep 30, 202446.14B5.25B12.84%
Sep 30, 202340.89B5.46B15.42%
Sep 30, 202235.43B1.44B4.22%
Sep 30, 202133.99B197.00M0.58%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition